These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10434678)

  • 1. [Spinal muscular atrophy: a hexosaminidase A deficiency phenotype].
    Kawanami T; Kato T
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):379-81. PubMed ID: 10434678
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tay-Sachs disease].
    Itoh T; Miura AB
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):389-92. PubMed ID: 9851170
    [No Abstract]   [Full Text] [Related]  

  • 3. Hexosaminidase A deficiency manifesting as spinal muscular atrophy of late onset.
    Karni A; Navon R; Sadeh M
    Ann Neurol; 1988 Sep; 24(3):451-3. PubMed ID: 2976262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tay-Sachs disease (beta-hexosaminidase alpha-chain deficiency)].
    Okada S; Taniike M
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):394-6. PubMed ID: 9645090
    [No Abstract]   [Full Text] [Related]  

  • 5. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
    Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease].
    Peleg L; Gazit E; Goldman B; Akstein E
    Harefuah; 1995 Dec; 129(11):475-80. PubMed ID: 8846957
    [No Abstract]   [Full Text] [Related]  

  • 7. The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis.
    Mahuran DJ
    Biochim Biophys Acta; 1991 Feb; 1096(2):87-94. PubMed ID: 1825792
    [No Abstract]   [Full Text] [Related]  

  • 8. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
    Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
    Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Juvenile GM2 gangliosidosis with progressive spinal muscular atrophy onset].
    Rondot P; Navon R; Eymard B; Fardeau M; Turpin JC; Lefevre M; Bathien N; Wu Y; Baumann N
    Rev Neurol (Paris); 1997 Mar; 153(2):120-3. PubMed ID: 9296123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of beta-hexosaminidase deficiencies.
    Neote K; Mahuran DJ; Gravel RA
    Adv Neurol; 1991; 56():189-207. PubMed ID: 1830186
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel HEXA mutation [1393G>A (D465N)] in a Mexican Tay-Sachs disease patient.
    Alvarez-Rodríguez A; Triggs-Raine B; Barros-Núñez P; Lozano CM
    Hum Mutat; 2001 May; 17(5):437. PubMed ID: 11317368
    [No Abstract]   [Full Text] [Related]  

  • 12. [GM2-Gangliosidosis variant B1 disclosed during adolescence by an isolated multi-systemic involvement of the central and peripheral nervous systems].
    Le Coz P; Assouline E; Vanier MT; Goutières F; Mikol J; Woimant F; Pinard JM; Aicardi J; Haguenau M
    Rev Neurol (Paris); 1994; 150(1):61-6. PubMed ID: 7801043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tay-Sachs disease: a case report.
    Arisoy AE; Ozden S; Ciliv G; Ozalp I
    Turk J Pediatr; 1995; 37(1):51-6. PubMed ID: 7732608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile-onset spinal muscular atrophy caused by compound heterozygosity for mutations in the HEXA gene.
    Navon R; Khosravi R; Melki J; Drucker L; Fontaine B; Turpin JC; N'Guyen B; Fardeau M; Rondot P; Baumann N
    Ann Neurol; 1997 May; 41(5):631-8. PubMed ID: 9153525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile spinal muscular atrophy: a new hexosaminidase deficiency phenotype.
    Johnson WG; Wigger HJ; Karp HR; Glaubiger LM; Rowland LP
    Ann Neurol; 1982 Jan; 11(1):11-6. PubMed ID: 6460466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and clinical heterogeneity of adult GM2 gangliosidosis.
    Navon R
    Dev Neurosci; 1991; 13(4-5):295-8. PubMed ID: 1840100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and molecular characterization of non-classic forms of Tay-Sachs disease in Brazil.
    Rozenberg R; Kok F; Burin MG; Sá Miranda MC; Vasques C; Henriques-Souza AM; Giugliani R; Vainzof M; Pereira LV
    J Child Neurol; 2006 Jun; 21(6):540-4. PubMed ID: 16948947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tay-Sachs disease in an Israeli Arab family: Trp26-->stop in the alpha-subunit of hexosaminidase A.
    Drucker L; Navon R
    Hum Mutat; 1993; 2(5):415-7. PubMed ID: 8257995
    [No Abstract]   [Full Text] [Related]  

  • 19. The beta-hexosaminidase deficiency disorders: development of a clinical paradigm in the mouse.
    Tifft CJ; Proia RL
    Ann Med; 1997 Dec; 29(6):557-61. PubMed ID: 9562524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical aspects of adult hexosaminidase deficiencies.
    Federico A; Palmeri S; Malandrini A; Fabrizi G; Mondelli M; Guazzi GC
    Dev Neurosci; 1991; 13(4-5):280-7. PubMed ID: 1840098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.